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Abstract:  Xestenone is a marine norditerpenoid found in the northeastern Pacific sponge 
Xestospongia vanilla. The relative configuration of C-3 and C-7 in xestenone was determined by 
NOESY spectral analysis. However the relative configuration of C-12 and the absolute 
configuration of this compound were not determined. The authors have now achieved the total 
synthesis of xestenone using their developed one-pot synthesis of cyclopentane derivatives 
employing allyl phenyl sulfone and an epoxy iodide as a key step. The relative and absolute 
configurations of xestenone were thus successfully determined by this synthesis. 
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1. Introduction 
 
The norditerpenoid xestenone (Figure 1) was first isolated from the marine sponge Xestospongia 
vanilla in 1988 [1]. Its planar structure was determined by 
1H- and 
13C-NMR and mass spectral 
analysis. The stereochemistry comprises two cis fused cyclopentane rings, as determined by the NOE 
correlation between the methyl protons at C-17 and the methine proton at C-3, although the relative 
configuration of C-12 and the absolute configuration were not determined. Moreover, no biological 
activity has been reported for xestenone, although various bioactive compounds that have been 
isolated from several Xestospongia sponges [2]. 
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Figure 1. Structure of xestenone. 
 
 
The authors recently reported a stereocontrolled one-pot synthesis of cyclopentane derivatives 
possessing a quaternary carbon, which involved: 1) reaction of an anion derived from allyl phenyl 
sulfone with epoxy iodide I to give epoxysulfone II; 2) in situ deprotonation of II to generate an  
epoxysulfone anion III and 3) intramolecular cyclization to give cyclopentane derivative IV (Scheme 
1) [3]. This one-pot synthesis of cyclopentane derivatives has now been applied to the total synthesis 
of xestenone, and in this paper the authors wish to report on the successful total synthesis of xestenone 
and its complete structural determination. 
 
Scheme 1. One-pot synthesis of cyclopentane derivatives. 
 
 
2. Results and Discussion 
 
2.1. Retrosynthetic analysis 
 
The authors planned to synthesize both xestenone and 12-epi-xestenone, since the relative 
configuration at C-12 of xestenone was unknown at the onset (Scheme 2). Xestenone was obtained 
from secoxestenone by intramolecular aldol condensation [4]. Secoxestenone would be obtained from 
α,β-unsaturated ketone A by 1,2-reduction of α,β-unsaturated ketone at C-12 and oxidation of the 
hydroxy group at C-2 and C-8. The α,β-unsaturated ketone A would be obtained from aldehyde B by 
the Horner-Wadsworth-Emmons reaction using known phosphonate C [5]. For the right hand fragment 
of xestenone, aldehyde B would be synthesized from cyclopentane D through various chemical Mar. Drugs 2009, 7       
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functionalizations. Cyclopentane D would be constructed by our developed stereocontrolled one-pot 
synthesis of cyclopentane derivatives using trisubstituted epoxy iodide E and allyl phenyl sulfone [3]. 
Epoxy iodide E would be obtained from alcohol F. 
 
Scheme 2. Retrosynthetic analysis of xestenone.  
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2.2. Synthesis of xestenone 
 
Geraniol was converted to alcohol 1 by known procedures [6]. Alcohol 1 was treated with p-TsCl 
and pyridine to give the corresponding tosylate (90%), which was deacetylated with K2CO3 in MeOH 
to furnish allylic alcohol 2 (94%; Scheme 3). Allylic alcohol 2 was converted to chiral β-epoxyalcohol 
using Sharpless asymmetric epoxidation under standard conditions [7] (94% ee). Iodination of the 
epoxy alcohol with NaI and NaHCO3 furnished epoxy iodide 3 (90%, 2 steps). Protection of the 
primary hydroxy group in 3 as the TBS ether gave the desired chiral epoxy iodide 4 (95%). 
 
Scheme 3. Synthesis of epoxy iodide 4. 
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The sulfonyl carbanion prepared from allyl phenyl sulfone (2.3 eq.) and 
nBuLi (2.2 eq.) was reacted 
with epoxy iodide 4 at −20 °C. Following confirmation of the disappearance of 4 by TLC,   
nBuLi (1.2 eq.) and Me3Al (1.5 eq.) were added at −78 °C to give cyclopentane 5 as the sole product 
(98%; Scheme 4). The trans-configuration of the vinyl and 1-hydroxy-2-silyloxyethyl groups in 
cyclopentane  5 was determined by NOE correlation between the vinyl proton at C-2 and methyl 
protons at C-17. The stereoselectivity of this reaction is presumably the result of steric hindrance 
between the phenyl sulfonyl group and the 1-hydroxy-2-silyloxyethyl group in the intermediate 
sulfonyl carbanion. 
 
Scheme 4. Synthesis of intermediate 5. 
 
 
Protection of the secondary hydroxy group of 5 with TBSOTf and 2,6-lutidine (Scheme 5) 
furnished bis-silyl ether 6 (quant.). The phenylsulfonyl group in 6 was removed by treatment with 
Na(Hg) and Na2HPO4 to give trisubstituted (E)-olefin 7 as a sole product (quant.). The E-configuration 
of the trisubstituted olefin in 7 was determined by NOE correlation between the vinyl proton at C-2 
and methyl protons at C-17, and the vinyl proton at C-2 and methylene protons at C-9. 
Diastereoselective hydroboration-oxidation of E-olefin 7 with catecholborane furnished a mixture of 
diol 8 and triol 8a. The stereochemistry of diol 8 was elucidated by NOESY spectral analysis. The 
NOE correlation between the methyl protons at C-17 and methine proton at C-3, and the methine 
proton at C-2 and methine proton at C-8 in diol 8 suggested that the methyl group and methine proton 
of cyclopentane were oriented in the same β-configuration. The mixture of diol 8 and triol 8a was 
treated with p-TsOH･H2O in acetone to give acetonide 9 (95%, 2 steps). Subsequent deprotection of 
the acetonide group in 9 and oxidative cleavage of the 1,2-diol with HIO4･2H2O afforded hemiacetal 
10, which was converted to homoallylic alcohols 11a (50%, 2 steps) and 11b (36%, 2 steps). These 
alcohols were easily separated by silica gel chromatography. The relative configurations of these 
homoallylic alcohols 11a and 11b were determined by chemical conversion and NOESY spectral 
analysis. Compounds 11a and 11b were converted to tetrahydrofurans 12a and 12b by treatment with 
p-TsCl, DMAP and Et3N (Scheme 6). The NOE correlations of 12a between the methylene protons at 
C-9 and methyl protons at C-17, and one of the methylene protons at C-4 and methyl protons at C-1 
suggested that the C-1 methyl group and allyl group were oriented on different faces of the 
tetrahydrofuran ring, therefore, the stereochemistry of the hydroxy group at C-8 in homoallylic alcohol 
11a was found to adopt a β-configuration. The NOE correlations of 12b between the methine proton at 
C-2 and methine proton at C-3, the methine proton at C-2 and methine proton at C-8, the methine 
proton at C-8 and methyl protons at C-17, the methine proton at C-3 and methyl protons at C-17, and 
the methyl protons at C-1 and one of the methylene protons at C-4 were observed. The results 
suggested that the C-1 methyl group and allyl group were oriented on the same face of the Mar. Drugs 2009, 7       
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tetrahydrofuran ring. Therefore, the stereochemistry of the hydroxy group at C-8 in homoallylic 
alcohol 11b was found to adopt an α-configuration. Both homoallylic alcohols 11a and 11b could be 
converted to xestenone. However, the chemical yield of the later steps in this synthesis from α-alcohol 
11b was low. Therefore, α-alcohol 11b was converted into β-alcohol 11a by inversion of the C-8 
stereocenter. The hydroxy group at C-2 in α-alcohol 11b was protected with TBDPSCl and imidazole 
to give TBDPS ether, which was oxidized with IBX [8] to afford the ketone. Diastereoselective 
reduction of the ketone with NaBH4 to the alcohol, followed by deprotection of the TBDPS group with 
TBAF furnished a mixture of the desired β-alcohol 11a (69%, 4 steps) and α-alcohol 11b (14%,  
4 steps). 
 
Scheme 5. Synthesis of diols 11a and 11b. 
 
 
Scheme 6. Determination of the relative configuration of 11a and 11b. 
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β-Alcohol  11a was converted to bis-silyl ether 13 by treatment with TBSOTf and 2,6-lutidine 
(99%), and was followed by ozonolysis to give aldehyde 14 (quant.), thereby completing the synthesis 
of the right hand fragment of xestenone in 14 steps from known alcohol 1 [6] (Scheme 7). Treatment 
of aldehyde 14 with the anion of phosphonate 15 [5] in THF at r.t. provided α,β-unsaturated ketone 16 
(49%). 1,2-Reduction of the α,β-unsaturated ketone 16 with NaBH4 in the presence of CeCl3･7H2O in 
MeOH [9] furnished allylic alcohol 17 as an inseparable mixture (99%, 1:1). Protection of the hydroxy 
group in allylic alcohol 17 with TrCl and DMAP in pyridine provided the trityl ether, and was 
followed by desilylation with TBAF to give diol 18 (quant., 2 steps). Oxidation of two hydroxy groups 
in diol 18 with TFAA, DMSO and Et3N generated diketone 19 (95%). Lewis acid-mediated 
deprotection of the trityl group in diketone 19 with Yb(OTf)3 furnished diketone 20 as an inseparable 
diastereomeric mixture of the hydroxy group at C-12 (79%). Diketone 20 corresponds to 
secoxestenone. 
 
Scheme 7. Synthesis of diketone 20. 
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Finally, intramolecular aldol condensation of diketone 20 was achieved by treatment with 0.1 M 
NaOH aq. to furnish a diastereomeric mixture of xestenone 21 and 12-epi-21  (88%; Scheme 8). 
Separation of the diastereomeric mixture using a chiral HPLC column gave 21 {[α]D
25 +2.2° (c 0.08, 
MeOH)}, and 12-epi-21 {[α]D
25 -113.7° (c 0.09, MeOH)}. The optical rotation of synthetic 21 is not Mar. Drugs 2009, 7       
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identical, but very close to the value obtained for the natural product {[α]D 0° (c 1.00, MeOH)} [1]. 
Moreover, the CD spectrum of the synthetic 21 matched that of the natural product [1]. The CD 
spectrum of the synthetic 21 showed a positive Cotton effect at 323 nm and a negative Cotton effect at 
258 nm. The absolute configuration of the hydroxy group at C-12 in 21 was determined by comparing 
the 
1H-NMR data of the two diastereomeric esters (MPA esters) [10]. The absolute configuration of 
the hydroxy group at C-12 in 12-epi-21 was determined by the same method. As a result, the absolute 
stereochemistry of the three chiral centers in xestenone was determined to be 3S, 7S and 12R.  
12-epi-xestenone (12-epi-21) was converted to xestenone (21) by a Mitsunobu reaction. 
 
Scheme 8. Synthesis of xestenone (21). 
 
 
3. Experimental Section 
 
3.1. General 
 
Optical rotations were measured using a Jasco P-1030 polarimeter. Melting points (mp) were 
measured using a Yazawa melting point apparatus BY-2 and are uncorrected. IR spectra were recorded 
using a Jasco FT-IR/620 spectrometer. UV spectra were recorded using a Jasco V-550 
spectrophotometer.  Circular dichroism (CD) spectra were measured with a Jasco J-720 
spectropolarimeter. 
1H- and 
13C-NMR spectra were recorded on a Bruker DRX-400 or a Bruker 
Biospin AV-600 spectrometer. Chemical shifts are given on the δ (ppm) scale using tetramethylsilane 
(TMS) as the internal standard (s, singlet; d, doublet; t, triplet; q, quartet; quint, quintet; m, multiplet; 
br, broad). High resolution ESIMS (HRESIMS) spectra were obtained using a Micromass LCT 
spectrometer. Elemental analysis data were obtained using an Elemental Vavio EL. Flash column 
chromatography was performed using Kanto Chemical Silica Gel 60N (spherical, neutral) 40–50 μm. 
 
3.2. (E)-6-Hydroxy-4-methylhex-4-enyl 4-methylbenzenesulfonate (2) 
 
To a solution of (E)-6-hydroxy-3-methylhex-2-enyl acetate [6] (1, 530 mg, 3.08 mmol) in CH2Cl2 
(10.3 mL) were added pyridine (374 μL, 4.62 mmol) and p-toluenesulfonyl chloride (705 mg,   Mar. Drugs 2009, 7       
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3.70 mmol) at 0 °C. After stirring for 5 hr at r.t., the mixture was diluted with Et2O, washed with H2O 
and brine, and then dried. Removal of the solvent gave a residue which was then purified by silica gel 
column chromatography (hexane/AcOEt = 2:1) to generate tosylate (905 mg, 90% yield) as a colorless 
oil. IR (neat) 2924, 1733, 1359 cm
-1; 
1H-NMR (400 MHz, CDCl3) δ ppm: 7.77 (2H, d, J = 8.2 Hz), 
7.33 (2H, d, J = 8.2 Hz), 5.25 (1H, m), 4.52 (2H, d, J = 7.2 Hz), 4.01 (2H, t, J = 6.4 Hz), 2.44 (3H, s), 
2.05 (2H, t, J = 7.2 Hz), 2.03 (3H, s), 1.77 (2H, m), 1.64 (3H, s); 
13C-NMR (100 MHz, CDCl3) δ ppm: 
170.9, 144.7, 133.3, 129.8, 127.8, 119.6, 69.8, 61.0, 35.0, 26.8, 21.5, 20.9, 16.2; HRESIMS (m/z) 
calcd. for C16H23O5S (M+H)
+ 349.1086, found 349.1086; Anal. Calcd. for C16H22O5S: C, 58.87; H, 
6.79. Found: C, 58.94; H, 6.75. 
To a solution of the above tosylate (9.47 g, 29.0 mmol) in MeOH (290 mL) was added K2CO3  
(4.81 g, 34.8 mmol) at r.t. After stirring for 30 min at the same temperature, the mixture was diluted 
with Et2O and then filtered through a silica gel pad. Removal of the solvent gave a residue which was 
then purified by silica gel column chromatography (hexane/AcOEt = 2:1) to generate allylic alcohol 2  
(7.74 g, 94% yield) as a colorless oil. IR (neat) 3387, 2923, 1354 cm
-1; 
1H-NMR (400 MHz, CDCl3) δ 
ppm: 7.75 (2H, d, J = 8.2 Hz), 7.32 (2H, d, J = 8.2 Hz), 5.31 (1H, m), 4.07 (2H, d, J = 6.5 Hz), 4.00 
(2H, t, J = 6.5 Hz), 2.42 (3H, s), 2.02 (2H, t, J = 7.8 Hz), 1.76 (2H, m), 1.59 (3H, s), 1.52 (1H, br s); 
13C-NMR (100 MHz, CDCl3) δ ppm: 144.7, 137.2, 133.2, 129.8, 127.8, 124.7, 69.8, 59.0, 35.0, 26.6, 
21.5, 15.9; HRESIMS (m/z) calcd. for C14H21O4S (M+H)
+ 307.0980, found 307.0994; Anal. Calcd. for 
C14H20O4S: C, 59.13; H, 7.09. Found: C, 59.07; H, 7.06. 
 
3.3. ((2S,3S)-3-(3-Iodopropyl)-3-methyloxiran-2-yl)methanol (3) 
 
To a cold (−20 °C) suspension of 4Å molecular sieves (114 mg) in CH2Cl2 (1.6 mL) were added  
L-(+)-DIPT (5.2 μL, 24.8 μmol), Ti(O
iPr)4 (6.2 μL, 21.0 μmol) and TBHP (164 μL, 101 mmol, 6.17 M 
in CH2Cl2 solution). After stirring for 30 min at the same temperature, a solution of allylic alcohol 2 
(54.4 mg, 191 μmol) in CH2Cl2 (500 μL) was added over 5 min. After stirring at −20 °C for 15 min, 
NaOH (13.0 μL, 30% in saturated aqueous NaCl) was added. The mixture was diluted with Et2O, 
warmed to r.t. and stirred for 10 min. MgSO4 (11.6 mg) and Celite (1.4 mg) were then added and after 
stirring for 15 min, the mixture was filtered through a Celite pad and the filtrate was concentrated 
under reduced pressure to afford the crude epoxide. To a solution of the crude epoxide in acetone  
(1.9 mL) were added NaHCO3 (17.7 mg, 210 μmol) and NaI (286 mg, 1.91 mmol) at r.t. After stirring 
for 8 hr at the same temperature, the mixture was diluted with Et2O and then filtered through a silica 
gel pad. Removal of the solvent gave a residue which was then purified by silica gel column 
chromatography (hexane/AcOEt = 1:2) to generate epoxy iodide 3 (44.0 mg, 90% yield) as a yellow 
oil. [α]D
28 -10.0 (c 1.03, CHCl3); IR (neat) 3418, 2929 cm
-1; 
1H-NMR (400 MHz, CDCl3) δ ppm:  
3.79 (1H, m), 3.68 (1H, m), 3.18 (2H, m), 2.97 (2H, t, J = 5.4 Hz), 1.99 (1H, br s), 1.93 (2H, m),  
1.64 (2H, m), 1.29 (3H, s); 
13C-NMR (100 MHz, CDCl3) δ ppm: 62.6, 61.2, 60.3, 39.0, 29.0, 16.8, 5.8; 
HRESIMS (m/z) calcd. for C7H12IO (M-OH)
+ 238.9933, found 238.9930; Anal. Calcd. for C7H13IO2: 
C, 32.83; H, 5.12. Found: C, 33.06; H, 5.26. 
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3.4. tert-Butyl(((2S,3S)-3-(3-iodopropyl)-3-methyloxiran-2-yl)methoxy)dimethylsilane (4) 
 
To a solution of epoxy iodide 3 (387 mg, 1.51 mmol) in CH2Cl2 (1.5 mL) were added Et3N  
(253 mg, 1.82 mmol), DMAP (185 mg, 1.51 mmol) and TBSCl (251 mg, 1.82 mmol) and the mixture 
was stirred at r.t. for 30 min. The mixture was diluted with Et2O, washed with saturated aqueous 
NaHCO3 solution, H2O and brine, and then dried. Removal of the solvent gave a residue which was 
then purified by silica gel column chromatography (hexane/AcOEt = 7:1) to generate epoxy iodide 4  
(530 mg, 95% yield) as a colorless oil. [α]D
25 +6.9 (c 1.06, CHCl3); IR (neat) 2929 cm
-1; 
1H-NMR  
(400 MHz, CDCl3) δ ppm: 3.76 (1H, dd, J = 11.5, 5.5 Hz), 3.69 (1H, dd, J = 11.5, 5.5 Hz), 3.19 (2H, t, 
J = 7.0 Hz), 2.91 (1H, t, J = 5.5 Hz), 1.95 (2H, m), 1.64 (2H, m), 1.26 (3H, s), 0.91 (9H, s), 0.07 (6H, 
s); 
13C-NMR (100 MHz, CDCl3) δ ppm: 62.8, 62.0, 59.5, 39.0, 29.2, 25.9, 18.3, 16.7, 5.8, -5.2, -5.4; 
HRESIMS (m/z) calcd. for C13H28IO2Si  (M+H)
+ 371.0903, found 371.0921; Anal. Calcd. for 
C13H27IO2Si: C, 42.16; H, 7.35. Found: C, 42.37; H, 7.23. 
 
3.5. (R)-1-[(1R,2S)-2-Benzenesulfonyl-1-methyl-2-vinylcyclopentyl]-2-(tert-butyldimethylsiloxy) 
ethanol (5) 
 
To a solution of allyl phenyl sulfone (95.2 mg, 0.552 mmol) in THF (3.0 mL) was added 
nBuLi 
(317 μL, 0.500 mmol, 1.58 M in hexane solution) at −78 °C and the mixture was warmed to 0 °C. The 
mixture was stirred for 30 min at the same temperature. After cooling to −78 °C, a solution of epoxy 
iodide  4 (84.1 mg, 0.227 mmol) in THF (1.6 mL) was added and the mixture was warmed to   
-20 °C. The mixture was stirred for 30 min at the same temperature. After cooling to −78 °C, 
nBuLi 
(173 μL, 0.273 mmol, 1.58 M in hexane solution) was added and the mixture was warmed to -20 °C. 
The mixture was stirred for 30 min at the same temperature. After cooling to −78 °C, Me3Al (331 μL, 
0.341 mmol, 1.03 M in hexane) was added. After stirring for 1 hr at the same temperature, the mixture 
was diluted with Et2O, washed with saturated aqueous NH4Cl solution, H2O and brine, and then dried. 
Removal of the solvent gave a residue which was then purified by silica gel column chromatography 
(hexane/AcOEt = 10:1) to generate cyclopentane 5 (94.4 mg, 98% yield) as a white solid. mp   
125–126 °C; [α]D
25 -114 (c 0.81, CHCl3); IR (KBr) 3560, 2952 cm
-1; 
1H-NMR (400 MHz, CDCl3) δ 
ppm: 7.78 (2H, m), 7.57 (1H, m), 7.45 (2H, m), 6.19 (1H, dd, J =  17.4, 10.9 Hz), 5.25 (1H, d,  
J = 10.9 Hz), 4.73 (1H, d, J = 17.4 Hz), 4.56 (1H, dt, J = 6.2, 2.9 Hz), 4.29 (1H, dd, J = 9.5, 3.5 Hz), 
3.67 (1H, t, J = 8.8 Hz), 3.23 (1H, d, J = 2.9 Hz), 2.57 (1H, m), 2.06 (3H, m), 1.73 (2H, m), 0.99 (3H, 
s), 0.93 (9H, s), 0.14 (6H, s); 
13C-NMR (100 MHz, CDCl3) δ ppm: 137.4, 135.3, 133.3, 130.6, 127.9, 
120.3, 81.0, 74.3, 64.2, 54.6, 37.2, 30.8, 25.9, 20.0, 19.6, 18.2, -5.1, -5.3; HRESIMS (m/z) calcd. for 
C22H37O4SSi (M+H)
+ 425.2182, found 425.2179; Anal. Calcd. for C22H36O4SSi: C, 62.22; H, 8.54. 
Found: C, 62.11; H, 8.41. 
 
3.6. {(1S,2R)-2-[(R)-1,2-Bis(tert-butyldimethylsiloxy)ethyl]-2-methyl-1-vinylcyclopentanesulfonyl} 
benzene (6) 
 
To a solution of cyclopentane 5 (7.01 g, 16.5 mmol) in CH2Cl2 (16.5 mL) were added 2,6-lutidine 
(17.7 g, 165 mmol) and TBSOTf (7.02 g, 26.6 mmol) and the mixture was stirred at 0 °C for 30 min. Mar. Drugs 2009, 7       
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The mixture was diluted with Et2O, washed with saturated aqueous NaHCO3 solution, H2O and brine, 
and then dried. Removal of the solvent gave a residue which was then purified by silica gel column 
chromatography (hexane/AcOEt = 5:1) to generate bis-silyl ether 6 (8.89 g, quantitative yield) as a 
colorless oil. [α]D
25 -77.9 (c 1.62, CHCl3); IR (neat) 2954, 1133 cm
-1; 
1H-NMR (400 MHz, CDCl3) δ 
ppm: 7.78 (2H, m), 7.57 (1H, m), 7.45 (2H, m), 6.37 (1H, dd, J = 17.4, 10.9 Hz), 5.27 (1H, d,  
J = 10.9), 4.72 (1H, d, J = 17.4 Hz), 4.63 (1H, dd, J = 5.9, 1.8 Hz), 4.15 (1H, dd, J = 10.5, 1.8 Hz), 
3.87 (1H, dd, J = 10.5, 5.9), 2.51 (1H, m), 2.12 (1H, m), 2.01 (1H, m), 1.90 (3H, m), 0.92 (21H, m), 
0.16 (12H, m); 
13C-NMR (100 MHz, CDCl3) δ ppm: 137.3, 135.3, 133.2, 130.7, 127.9, 120.7, 81.1, 
77.2, 66.5, 56.3, 40.0, 31.6, 26.3, 26.2, 19.8, 19.0, 18.5, -3.3, -4.6, -5.1, -5.4; HRESIMS (m/z) calcd. 
for C28H51O4SSi2 (M+H)
+ 539.3047, found 539.3086; Anal. Calcd. for C28H50O4SSi2: C, 62.40; H, 
9.35. Found: C, 62.37; H, 9.11. 
 
3.7. (S)-1-[(R)-1,2-Bis(tert-butyldimethylsiloxy)ethyl]-2-ethylidene-1-methylcyclopentane (7) 
 
To a solution of bis-silyl ether 6 (9.29 g, 17.2 mmol) in MeOH (344 mL) were added Na2HPO4 
(17.1 g, 120.5 mmol) and 5% Na(Hg) (31.6 g). After stirring for 1 hr at r.t., the mixture was diluted 
with Et2O and filtered through silica gel. The filtrate was then concentrated under reduced pressure. 
The resultant residue was then purified by silica gel column chromatography (hexane only) to generate 
E-olefin  7 (6.86 g, quantitative yield) as a colorless oil. [α]D
25 +19.0 (c 1.35, CHCl3); IR (neat)   
2955 cm
-1; 
1H-NMR (400 MHz, CDCl3) δ ppm: 5.17 (1H, m), 3.78 (1H, dd, J = 10.3, 2.8 Hz), 3.52 
(1H, dd, J = 9.2, 1.8 Hz), 3.46 (1H, dd, J = 10.3, 5.8 Hz), 2.35 (1H, m), 2.08 (2H, m), 1.67 (1H, m), 
1.58 (3H, d, J = 6.7 Hz), 1.53 (2H, m), 1.22 (1H, m), 0.97 (3H, s), 0.88 (9H, s), 0.86 (9H, s), 0.07 (3H, 
s), 0.03 (3H, s), 0.03 (3H, s), 0.00 (3H, s); 
13C-NMR (100 MHz, CDCl3) δ ppm: 150.2, 114.1, 79.1, 
66.3, 49.5, 35.7, 30.0, 26.1, 26.0, 23.9, 22.5, 18.4, 18.3, 14.7, -3.9, -5.0, -5.3; HRESIMS (m/z) calcd. 
for C22H46O2Si2Na (M+Na)
+ 421.2934, found 421.2914; Anal. Calcd. for C22H46O2Si2: C, 66.26; H, 
11.63. Found: C, 66.36; H, 11.50. 
 
3.8. (S)-1-{(1R,2S)-2-[(R)-2,2-Dimethyl-[1,3]dioxolan-4-yl]-2-methylcyclopentyl}ethanol (9) 
 
To a solution of E-olefin 7 (3.86 g, 9.69 mmol) in THF (19.4 mL) was added catecholborane  
(6.40 mL, 60.1 mmol) dropwise at 0 °C. After stirring for 12 hr at the same temperature, 1M NaOH 
solution (12.9 mL) and 35% aqueous H2O2 solution (36.9 mL) were added to the mixture at r.t. After 
stirring for 2 hr, the resultant mixture was diluted with CHCl3, washed with H2O and brine, dried and 
then concentrated to afford a mixture of diol 8 and triol 8a. To a solution of the crude alcohols in 
acetone (96.9 mL) was added p-TsOH･H2O (735 mg, 3.88 mmol) at r.t. After stirring for 2 hr at the 
same temperature, the mixture was diluted with Et2O, washed with saturated aqueous NaHCO3 
solution, H2O and brine, and then dried. Removal of the solvent gave a residue which was then 
purified by silica gel column chromatography (hexane/acetone = 4:1) to generate acetonide 9 (2.11 g, 
95% yield) as a colorless oil. [α]D
25 +4.0 (c 0.58, CHCl3); IR (neat) 3443, 2956 cm
-1; 
1H-NMR (400 
MHz, CDCl3) δ ppm: 4.42 (1H, dd, J = 8.5, 6.5 Hz), 4.01 (1H, m), 3.96 (1H, dd, J = 7.8, 6.5 Hz), 3.66 
(1H, t, J = 8.2 Hz), 2.07 (1H, s), 1.89 (1H, m), 1.69–1.50 (4H, m), 1.41 (3H, s), 1.35 (3H, s), 1.37–1.33 
(2H, m), 1.20 (3H, d, J = 6.2 Hz), 1.07 (3H, s); 
13C-NMR (100 MHz, CDCl3) δ ppm: 108.5, 79.9, 69.3, Mar. Drugs 2009, 7       
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66.9, 59.1, 45.1, 35.0, 31.2, 27.8, 26.5, 25.3, 24.2, 23.3; HRESIMS (m/z) calcd. for C13H25O3 (M+H)
+ 
229.1804, found 229.1810; Anal. Calcd. for C13H24O3: C, 68.38; H, 10.59. Found: C, 68.43; H, 10.59. 
 
3.9. (R)-1-[(1S,2R)-2-((S)-1-Hydroxyethyl)-1-methylcyclopentyl]but-3-en-1-ol (11a) and (S)-1-
[(1S,2R)-2-((S)-1-hydroxyethyl)-1-methylcyclopentyl]but-3-en-1-ol (11b) 
 
To a solution of acetonide 9 (2.11 g, 9.24 mmol) in THF was added a solution of HIO4･2H2O  
(12.6 g, 55.4 mmol) in H2O (93.0 mL) at r.t. After stirring for 3 hr at 45 °C, the mixture was diluted 
with Et2O, washed with H2O and brine, dried and then concentrated to afford crude hemiacetal 10. To 
a solution of crude hemiacetal 10 in Et2O (93.0 mL) was added allyl magnesium bromide (33.0 mL, 
32.3 mmol, 1.0 M in Et2O solution) at −78 °C. After stirring for 1 hr at 0 °C, the mixture was diluted 
with Et2O, washed with saturated aqueous NH4Cl solution, H2O and brine, and then dried. Removal of 
the solvent gave a residue which was then purified by silica gel column chromatography 
(hexane/AcOEt = 8:1) to generate diol 11a (914 mg, 50% yield) as a colorless oil and diol 11b  
(650 mg, 36 % yield) as a white solid. Compound 11a: [α]D
25 -5.0 (c 0.39, CHCl3); IR (neat) 3306, 
2955 cm
-1; 
1H-NMR (400 MHz, CDCl3) δ ppm: 5.87 (1H, m), 5.19 (1H, d, J = 10.4 Hz), 5.18 (1H, d,  
J = 16.8 Hz), 3.86 (1H, m), 3.68 (1H, dd, J =10.5, 2.3 Hz), 3.18 (2H, br s), 2.34 (1H, m), 2.13 (1H, m), 
1.80 (1H, m), 1.62–1.34 (5H, m), 1.22 (1H, m), 1.17 (3H, d, J = 6.2 Hz), 1.09 (3H, s); 
13C-NMR  
(100 MHz, CDCl3) δ ppm: 136.1, 118.7, 72.5, 69.2, 58.8, 47.8, 39.5, 37.1, 30.2, 22.7, 22.5, 22.4; 
HRESIMS (m/z) calcd. for C12H23O2 (M+H)
+ 199.1698, found 199.1713; Anal. Calcd. for C12H22O2: C, 
72.68; H, 11.18. Found: C, 72.40; H, 10.99. Compound 11b: mp 93–95 °C; [α]D
25 -35.0 (c 0.20, 
CHCl3); IR (KBr) 3351, 2953 cm
-1; 
1H-NMR (400 MHz, CDCl3) δ ppm: 5.30 (1H, m), 5.18 (1H, d,  
J = 10.2 Hz), 5.17 (1H, d, J = 16.9 Hz), 4.11 (1H, m), 3.76 (1H, dd, J = 10.8, 2.1 Hz), 2.48 (1H, m), 
2.27 (2H, br s), 2.13 (1H, m), 1.85 (1H, m), 1.67 (2H, m), 1.60 (2H, m), 1.45 (2H, m,), 1.22 (3H, d,  
J = 6.2 Hz ), 1.19 (3H, s); 
13C-NMR (100 MHz, CDCl3) δ ppm: 136.2, 118.6, 75.7, 69.5, 59.5, 47.5, 
37.8, 36.5, 32.0, 29.5, 23.9, 23.4; HRESIMS (m/z) calcd. for C12H23O2 (M+H)
+ 199.1698, found 
199.1681; Anal. Calcd. for C12H22O2: C, 72.68; H, 11.18. Found: C, 72.65; H, 10.91. 
 
3.10. (1R,2R,3aS,3R)-3-Allyl-1,3a-dimethylhexahydrocyclopenta[c]furan (12a) 
 
To a solution of diol 11a (34.4 mg, 0.174 mmol) in CH2Cl2 (1.7 mL) were added Et3N (105 mg, 
1.04 mmol), DMAP (106 mg, 0.868 mmol) and p-toluenesulfonyl chloride (132 mg, 0.694 mmol) at 
r.t. The mixture was stirred for two days at the same temperature. The mixture was diluted with Et2O, 
washed with saturated aqueous NH4Cl solution, H2O and brine, and then dried. Removal of the solvent 
gave a residue which was then purified by silica gel column chromatography (hexane/AcOEt = 10:1) 
to generate tetrahydrofuran 12a (24.1 mg, 77% yield) as a colorless oil. [α]D
26 +21.5 (c 1.58, CHCl3); 
IR (neat) 2953, 2870 cm
-1; 
1H-NMR (400 MHz, CDCl3) δ ppm: 5.84 (1H, m), 5.09 (1H, m), 5.03 (1H, 
m), 4.25 (1H, quint., J = 6.5 Hz), 3.64 (1H, dd, J = 9.0, 4.8 Hz), 2.30–2.15 (2H, m), 2.07 (1H, m),  
1.68–1.59 (5H, m), 1.46 (1H, m), 1.16 (3H, d, J = 6.5 Hz), 1.07 (3H, s); NOESY correlations (H/H):  
H-1/H-4; H-3/H-17; H-9/H-17; 
13C-NMR (100 MHz, CDCl3) δ ppm: 136.7, 116.4, 85.0, 74.5, 57.0, 
39.1, 35.4, 27.3, 26.5, 22.1, 17.3; HRESIMS (m/z) calcd. for C12H21O  (M+H)
+ 181.1592, found 
181.1590; Anal. Calcd. for C12H20O: C, 79.94; H, 11.18. Found: C, 80.11; H, 11.10.  Mar. Drugs 2009, 7       
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3.11. (1R,2R,3aS,3S)-3-Allyl-1,3a-dimethylhexahydrocyclopenta[c]furan (12b) 
 
To a solution of diol 11b (32.4 mg, 0.163 mmol) in CH2Cl2 (1.6 mL) were added Et3N (82.8 mg, 
0.817 mmol), DMAP (79.9 mg, 0.654 mmol) and p-toluenesulfonyl chloride (93.5 mg, 0.490 mmol) at 
r.t. The mixture was stirred for 2 days at the same temperature. The mixture was diluted with Et2O, 
washed with saturated aqueous NH4Cl solution, H2O and brine, and then dried. Removal of the solvent 
gave a residue which was then purified by silica gel column chromatography (hexane/AcOEt = 5:1) to 
generate tetrahydrofuran 12b (27.1 mg, 93% yield) as a colorless oil. [α]D
26 -35.1 (c 1.14, CHCl3); IR 
(neat) 2951, 2866 cm
-1; 
1H-NMR (400 MHz, CDCl3) δ ppm: 5.87 (1H, m), 5.12 (1H, m), 5.04 (1H, m), 
3.84 (1H, quint., J = 6.4 Hz), 3.32 (1H, dd, J = 8.4, 4.9 Hz), 2.36–2.23 (2H, m), 1.97 (1H, m),  
1.63–1.59 (6H, m), 1.19 (3H, d, J = 6.5 Hz), 1.07 (3H, s); NOESY correlations (H/H): H-1/H-4;  
H-2/H-3; H-2/H-8; H-3/H-17; H-8/H-17; 
13C-NMR (100 MHz, CDCl3) δ ppm: 136.1, 116.3, 86.9, 
75.4, 56.1, 35.1, 34.7, 30.0, 27.7, 26.8, 25.9, 15.5; HRESIMS (m/z) calcd. for C12H21O (M+H)
+ 
181.1592, found 181.1577; Anal. Calcd. for C12H20O: C, 79.94; H, 11.18. Found: C, 79.91; H, 11.14.  
 
3.12. Conversion from diol 11b to diol 11a 
 
To a solution of diol 11b (50.0 mg, 0.252 mmol) in DMF (252 μL) were added imidazole (21.0 mg, 
0.308 mmol) and TBDPSCl (83.5 mg, 0.304 mmol) and the mixture was stirred at r.t. for 1 hr. The 
mixture was diluted with Et2O, washed with saturated aqueous NaHCO3 solution, H2O and brine and 
then dried. The crude mixture was diluted with Et2O and filtered through a silica gel pad. The filtrate 
was concentrated to afford the crude alcohol. To a solution of the crude alcohol in CH3CN (2.5 mL) 
was added IBX (212 mg, 0.757 mmol) at r.t. After stirring for 30 min at 80 °C, the mixture was diluted 
with Et2O and then filtered through a Celite pad. Removal of the solvent gave a residue which was 
filtered through a silica gel pad to afford the crude ketone. To a solution of the crude ketone in MeOH 
(2.5 mL) was added NaBH4 (28.6 mg, 0.756 mmol) at r.t. After stirring for 2 hr under reflux, the 
mixture was diluted with Et2O, washed with H2O and brine and then dried. Removal of the solvent 
gave a residue which was then filtered through a silica gel pad to afford the crude alcohols. To a 
solution of the crude alcohols in THF (2.5 mL) was added TBAF (760 μL, 0.760 mmol, 1.0 M in THF 
solution) at r.t. After stirring for 12 hr at 40 °C, the mixture was diluted with Et2O, washed with H2O 
and brine and then dried. Removal of the solvent gave a residue which was then purified by silica gel 
column chromatography (hexane/AcOEt = 4:1) to generate diol 11a (34.6 mg, 69%) and diol 11b  
(6.9 mg, 14 %). 
 
3.13. (1S,2R)-1-[(R)-1-(tert-Butyldimethylsiloxy)but-3-enyl]-2-[(S)-1-(tert-butyldimethylsiloxy)ethyl]-
1-methylcyclopentane (13) 
 
To a solution of diol 11a (988 mg, 4.98 mmol) in CH2Cl2 (2.7 mL) were added 2,6-lutidine (2.67 g, 
24.9 mmol) and TBSOTf (3.95 g, 14.9 mmol) and the mixture was stirred at 0 °C for 30 min. The 
mixture was diluted with Et2O, washed with saturated aqueous NaHCO3 solution, H2O and brine, and 
then dried. Removal of the solvent gave a residue which was then purified by silica gel column 
chromatography (hexane only) to generate bis-silyl ether 13 (2.11 g, 99% yield) as a colorless oil. Mar. Drugs 2009, 7       
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[α]D
25 +0.97 (c 1.07, CHCl3); IR (neat) 2956, 2885, 1471 cm
-1; 
1H-NMR (400 MHz, CDCl3) δ ppm: 
5.90 (1H, m), 5.00 (2H, m), 4.13 (1H, quint, J = 6.1 Hz), 3.80 (1H, dd, J = 6.5, 3.7 Hz), 2.38 (1H, m), 
2.22 (1H, m), 1.85–1.57 (6H, m), 1.19 (1H, m), 1.09 (3H, d, J = 6.1 Hz), 1.04 (3H, s), 0.89 (9H, s), 
0.88 (9H, s), 0.06 (12H, m); 
13C-NMR (100 MHz, CDCl3) δ ppm: 137.7, 115.8, 77.2, 76.8, 69.1, 56.6, 
50.1, 40.3, 35.1, 27.4, 27.1, 26.2, 26.0, 22.5, 18.4, 18.1, -3.0, -3.4, -3.6, -4.0; HRESIMS (m/z) calcd. 
for C24H51O2Si2 (M+H)
+ 427.3428, found 427.3437; Anal. Calcd. for C24H50O2Si2: C, 67.54; H, 11.81. 
Found: C, 67.44; H, 11.66. 
 
3.14. (R)-3-(tert-Butyldimethylsiloxy)-3-{(1S,2R)-2-[(S)-1-(tert-butyldimethylsiloxy)ethyl]-1-methyl-
cyclopentyl}propionaldehyde (14) 
 
A cold (-78 °C) solution of bis-silyl ether 13 (482 mg, 1.13 mmol) in CH2Cl2 (56.5 mL) was treated 
with ozone until the blue color generated persisted for more than 15 min. Excess ozone was removed 
using an argon flow. To the mixture were then added MeOH (56.5 mL), Zn powder (739 mg,   
11.3 mmol), KI (1.88 g, 11.3 mmol) and AcOH (682 mg, 11.4 mmol). The mixture was allowed to 
warm to r.t., stirred for 1 hr at the same temperature and then concentrated under reduced pressure. 
The resultant residue was diluted with Et2O, washed with saturated aqueous NaHCO3 solution, H2O 
and brine and then dried. Removal of the solvent gave a residue which was then purified by silica gel 
column chromatography (hexane/AcOEt = 20:1) to generate aldehyde 14 (484 mg, quantitative yield) 
as a colorless oil. [α]D
25 -0.56 (c 1.08, CHCl3); IR (neat) 2955, 2857, 1727 cm
-1; 
1H-NMR (400 MHz, 
CDCl3) δ ppm: 9.85 (1H, dd, J =  2.7, 1.3 Hz), 4.42 (1H, dd, J =  6.0, 4.1 Hz), 4.10 (1H, quint,  
J = 6.1 Hz), 2.67 (2H, m), 1.84 (1H, m), 1.74 (2H, m), 1.61 (3H, m), 1.23 (1H, m), 1.12 (3H, d,  
J = 6.1 Hz), 1.05 (3H, s), 0.88 (9H, s), 0.88 (9H, s), 0.06 (12H, m); 
13C-NMR (100 MHz, CDCl3) δ 
ppm: 201.9, 70.9, 69.0, 56.3, 50.5, 49.6, 35.4, 27.3, 26.7, 26.0, 22.4, 22.3, -3.4, -3.7, -4.0, -4.1; 
HRESIMS (m/z) calcd. for C23H48O3Si2Na (M+Na)
+ 451.3040, found 451.3052; Anal. Calcd. for 
C23H48O3Si2: C, 64.42; H, 11.28. Found: C, 64.40; H, 11.10. 
 
3.15. (6E,9R)-9-(tert-Butyldimethylsiloxy)-9-{(1R,2S)-2-[(S)-1-(tert-butyldimethylsiloxy)ethyl]-1-
methylcyclopentyl}-2,6-dimethylnona-2,6-dien-5-one (16) 
 
To a solution of phosphonate 15 [5]
 (306 mg, 1.17 mmol) in THF (700 μL) was added 
nBuLi  
(591 μL, 0.935 mmol, 1.58 M in hexane solution) at 0 °C. The mixture was stirred for 1 hr at the same 
temperature and a solution of aldehyde 14 (200 mg, 0.467 mmol) in THF (4.0 mL) was added 
dropwise at r.t. After stirring for 5 hr, the mixture was diluted with Et2O, washed with saturated 
aqueous NH4Cl solution, H2O and brine, and then dried. Removal of the solvent gave a residue which 
was then purified by silica gel column chromatography (hexane/benzene = 4:1) to generate   
α,β-unsaturated ketone 16 (123 mg, 49% yield) as a white solid and recovered aldehyde 14 (36.5 mg, 
18% yield). Compound 16: mp 55–58 °C; [α]D
25 +11.2 (c 0.57, CHCl3); UV (MeOH) λmax (ε) nm: 234 
(18800); IR (KBr) 2956, 2931, 2856, 1674 cm
-1; 
1H-NMR (400 MHz, CDCl3) δ ppm: 6.83 (1H, t,  
J = 6.1 Hz), 5.34 (1H, m), 4.10 (1H, quint, J = 6.2 Hz), 3.97 (1H, t, J = 5.6 Hz), 3.38 (2H, d,  
J = 7.0 Hz), 2.49 (2H, m), 1.85 (1H, m), 1.78 (3H, s), 1.74 (3H, s), 1.80–1.74 (2H, m), 1.64 (3H, s), 
1.64–1.57 (4H, m), 1.11 (3H, d, J = 6.1 Hz), 1.06 (3H, s), 0.90 (9H, s), 0.88 (9H, s), 0.08 (6H, d,  Mar. Drugs 2009, 7       
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J = 12.6 Hz), 0.06 (6H, d, J = 6.5 Hz); 
13C-NMR (100 MHz, CDCl3) δ ppm: 199.9, 141.5, 136.9, 
134.6, 117.1, 77.2, 75.9, 69.1, 56.5, 50.1, 37.1, 35.6, 35.1, 27.2, 27.1, 26.1, 26.0, 25.7, 22.5, 22.4, 18.3, 
18.1, 11.9, -3.2, -3.4, -3.8, -3.9; HRESIMS (m/z) calcd. for C31H61O3Si2 (M+H)
+ 537.4159, found 
537.4168; Anal. Calcd. for C31H60O3Si2: C, 69.34; H, 11.26. Found: C, 69.40; H, 11.05. 
 
3.16. (5R,6E,9R)-9-(tert-Butyldimethylsiloxy)-9-{(1R,2S)-2-[(S)-1-(tert-butyldimethylsiloxy)ethyl]-1-
methylcyclopentyl}-2,6-dimethylnona-2,6-dien-5-ol and (5S,6E,9R)-9-(tert-butyldimethylsiloxy)-9-
{(1R,2S)-2-[(S)-1-(tert-butyldimethylsiloxy)ethyl]-1-methylcyclopentyl}-2,6-dimethylnona-2,6-dien-5-
ol (17) 
 
To a solution of CeCl3·7H2O (144 mg, 0.386 mmol) in MeOH (9.3 mL) was added NaBH4  
(11.0 mg, 0.290 mmol) at 0 °C. The mixture was then added to a solution of α,β-unsaturated ketone 16 
(104 mg, 0.193 mmol) in MeOH (10.0 mL) at 0 °C and stirred for 30 min at the same temperature. The 
mixture was diluted with Et2O, washed with H2O and brine, and then dried. Removal of the solvent 
gave a residue which was then purified by silica gel column chromatography (CHCl3 only) to generate 
a diastereomeric mixture of allylic alcohol 17 (103 mg, 99% yield) as a colorless oil. IR (neat) 3353, 
2957 cm
-1; 
1H-NMR (400 MHz, CDCl3) δ ppm: 5.54 (1H, m), 5.11 (1H, m), 4.14 (1H, m), 4.00 (1H, 
m), 3.80 (1H, m), 2.42–2.14 (4H, m), 1.86 (1H, m), 1.80–1.57 (5H, m), 1.72 (3H, s), 1.64 (3H, s), 1.62 
(3H, s), 1.15 (1H, m), 1.09 (3H, d, J = 6.1 Hz), 1.02 (1.5 H, s), 1.02 (1.5H, s), 0.88 (9H, d, J = 6.9 Hz), 
0.88 (9H, d, J = 5.4 Hz), 0.06 (12H, m); 
13C-NMR (100 MHz, CDCl3) δ ppm: 136.6, 136.5, 134.8, 
134.7, 125.6, 125.5, 120.2, 120.2, 77.2, 77.2, 68.9, 68.9, 56.2, 56.2, 50.2, 50.2, 35.1, 35.0, 34.1, 34.0, 
26.7, 26.6, 26.5, 26.3, 26.2, 26.0, 25.9, 22.5, 22.1, 22.1, 22.1, 18.4, 18.1, 18.0, 12.1, 12.1, -3.1, -3.2,  
-3.4, -3.5, -3.7, -3.7, -4.0, -4.0; HRESIMS (m/z) calcd. for C31H62O3Si2Na (M+Na)
+ 561.4135, found 
561.4156; Anal. Calcd. for C31H62O3Si2: C, 69.08; H, 11.59. Found: C, 68.92; H, 11.30. 
 
3.17. (1R,3E,5R)-1-[(1S,2R)-2-((S)-1-Hydroxyethyl)-1-methylcyclopentyl]-4,8-dimethyl-5-trityloxy-
nona-3,7-dien-1-ol and (1R,3E,5S)-1-[(1S,2R)-2-((S)-1-hydroxyethyl)-1-methylcyclopentyl]-4,8-
dimethyl-5-trityloxynona-3,7-dien-1-ol (18) 
 
To a solution of the diastereomeric mixture of allylic alcohol 17 (40.0 mg, 0.074 mmol) in pyridine 
(740 μL) were added DMAP (5.0 mg, 0.041 mmol) and TrCl (103 mg, 0.395 mmol) at r.t. After 
stirring for 4 days at 80 °C, the mixture was diluted with Et2O, washed with H2O and brine, and then 
dried. Removal of the solvent gave a residue which was filtered through a short-path silica gel pad 
(hexane/AcOEt = 20:1). The filtrate was then concentrated to afford the crude trityl ether. To a 
solution of the crude trityl ether in DMF (1.5 mL) was added TBAF (1.5 mL, 0.150 mmol, 1.0 M in 
THF solution) at r.t. After stirring for 2 days at 50 °C, the mixture was diluted with Et2O, washed with 
H2O and brine and then dried. Removal of the solvent gave a residue which was then purified by silica 
gel column chromatography (hexane/AcOEt = 10:1) to generate a diastereomeric mixture of diol 18 
(40.9 mg, quantitative yield) as a colorless oil. IR (neat) 3344, 2961 cm
-1; 
1H-NMR (400 MHz, CDCl3) 
δ ppm: 7.51 (6H, m), 7.30–7.20 (9H, m), 4.93 (1H, t, J = 6.6 Hz), 4.77 (0.5H, dd, J = 6.7, 6.7 Hz), 4.68 
(0.5H, dd, J = 9.0, 5.5 Hz), 4.00 (1H, dd, J = 5.7, 5.7 Hz), 3.79 (0.5H, m), 3.73 (0.5H, m), 3.47–3.36 
(1H, m), 2.31 (0.5H, m), 2.12–1.88 (3.5 H, m), 1.82–1.73 (2.5H, m), 1.63 (3H, m), 1.54 (3H, m), 1.48 Mar. Drugs 2009, 7       
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(3H, m), 1.57–1.43 (2.5H, m), 1.41–1.31 (2H, m), 1.17 (1.5H, m), 1.14 (1.5H, m), 1.07 (3H, m); 
13C- 
NMR (100 MHz, CDCl3) δ ppm: 145.1, 140.4, 140.3, 133.7, 133.2, 129.0, 127.5, 127.5, 126.9, 126.9, 
122.1, 121.4, 120.6, 120.4, 87.2, 87.2, 79.5, 78.5, 77.2, 72.6, 72.3, 69.0, 68.9, 59.1, 47.3, 47.2, 39.6, 
33.1, 33.0, 30.3, 30.1, 30.1, 29.6, 29.2, 26.1, 25.8, 25.7, 22.4, 22.4, 22.3, 22.3, 22.2, 17.7, 12.7, 11.6; 
HRESIMS (m/z) calcd. for C38H48O3Na  (M+Na)
+ 575.3501, found 575.3522; Anal. Calcd. for 
C38H48O3: C, 82.56; H, 8.75. Found: C, 82.52; H, 8.60. 
 
3.18. (3E,5R)-1-((1S,2R)-2-Acetyl-1-methylcyclopentyl)-4,8-dimethyl-5-trityloxynona-3,7-dien-1-one 
and (3E,5S)-1-((1S,2R)-2-acetyl-1-methylcyclopentyl)-4,8-dimethyl-5-trityloxynona-3,7-dien-1-one 
(19) 
 
To a cold (−78 °C) solution of TFAA (67.6 mg, 0.322 mmol) in CH2Cl2 (100 μL) was added 
DMSO (33.6 mg, 0.430 mmol) in CH2Cl2 (100 μL). The mixture was stirred at −78 °C for 30 min, 
treated with a solution of the diastereomeric mixture of diol 18 (29.6 mg, 0.054 mmol) in CH2Cl2  
(340 μL), stirred for 2 hr and then Et3N (54.3 mg, 0.537 mmol) was added. The mixture was warmed 
to r.t. and stirred for 30 min. The mixture was diluted with Et2O, washed with saturated aqueous 
NaHCO3 solution, H2O and brine and then dried. Removal of the solvent gave a residue which was 
then purified by silica gel column chromatography (hexane/AcOEt = 6:1) to generate a diastereomeric 
mixture of diketone 19 (27.9 mg, 95% yield) as a colorless oil. IR (neat) 2965, 1705 cm
-1; 
1H-NMR 
(400 MHz, CDCl3) δ ppm: 7.49 (6H, m), 7.26–7.16 (9H, m), 4.95 (1H, t, J = 6.1 Hz), 4.81 (1H, t,  
J = 7.3 Hz), 3.92 (1H, dd, J = 8.8, 4.7 Hz), 2.92 (2H, m), 2.78 (1H, dd, J = 8.6, 5.0 Hz), 2.23–1.72 (6H, 
m), 2.15 (3H, s), 1.63–1.55 (2H, m), 1.58 (3H, s), 1.48 (3H, s), 1.42 (3H, s), 1.21 (3H, s); 
13C-NMR 
(100 MHz, CDCl3) δ ppm: 212.2, 210.7, 145.2, 137.6, 132.4, 129.2, 127.5, 126.8, 120.5, 118.7, 87.2, 
79.3, 77.2, 60.9, 59.8, 37.9, 35.4, 33.5, 29.9, 27.6, 25.8, 25.2, 22.4, 17.8, 12.1; HRESIMS (m/z) calcd. 
for C38H44O3Na (M+Na)
+ 571.3188, found 571.3196. Anal. Calcd. for C38H44O3: C, 83.17; H, 8.08. 
Found: C, 83.12; H, 8.21. 
 
3.19. Diastereomeric mixture of secoxestenone (20) 
 
To a solution of the diastereomeric mixture of diketone 19 (76.2 mg, 0.139 mmol) in CH2Cl2 (14 
mL) was added Yb(OTf)3 (172 mg, 0.277 mmol) at r.t. After stirring for 30 min, the mixture was 
diluted with Et2O. To this was added NaHCO3 and the mixture was then filtered through a silica gel 
pad. Removal of the solvent gave a residue which was then purified by silica gel column 
chromatography (hexane/AcOEt = 1:1) to generate a diastereomeric mixture of secoxestenone 20 (33.5 
mg, 79% yield) as a colorless oil. IR (neat) 3448, 2965, 1706 cm
-1; 
1H-NMR (400 MHz, CDCl3) δ 
ppm: 5.60 (1H, m), 5.10 (1H, m), 4.05 (1H, m), 3.27 (2H, m), 2.85 (1H, m), 2.27 (3H, m), 2.16 (3H, 
m), 2.09 (1H, m), 1.91–1.75 (3H, m), 1.71 (3H, s), 1.66 (1H, m), 1.63 (3H, s), 1.63 (3H, s), 1.28 (3H 
m); 
13C-NMR (100 MHz, CDCl3) δ ppm: 212.8, 210.8, 148.5, 141.9, 134.7, 120.8, 120.1, 118.2, 77.2, 
76.9, 61.3, 60.4, 59.7, 37.8, 35.9, 35.5, 34.0, 30.2, 29.8, 27.8, 27.7, 25.9, 25.7, 25.6, 25.3, 22.4, 18.0, 
12.3, 12.1; HRESIMS (m/z) calcd. for C19H30O3Na (M+Na)
+ 329.2093, found 329.2085. Anal. Calcd. 
for C19H30O3: C, 74.47; H, 9.87. Found: C, 74.29; H, 9.85. 
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3.20. Xestenone (21) and 12-epi-xestenone (12-epi-21) 
 
To a solution of the diastereomeric mixture of secoxestenone 20 (26.5 mg, 0.087 mmol) in MeOH 
(6.7 mL) was added 0.1 M NaOH aqueous solution (21.6 mL) at r.t. The mixture was stirred for  
30 min, neutralized with 1.0 M HCl aqueous solution, diluted with Et2O, washed with H2O and brine, 
dried and then concentrated under reduced pressure. The resultant residue was purified by silica gel 
column chromatography (hexane/AcOEt = 4:1) to give a mixture of 21 and 12-epi-21 (22.0 mg, 88% 
yield) as a colorless oil. The above mixture was subjected to HPLC (CHIRALPAK IA,   
1.0 cm × 25 cm, hexane/EtOH = 95:5, flow rate: 1.0 mL/min) to give xestenone 21 (tR = 12.0 min) and 
12-epi-21 (tR = 15.0 min); 21: [α]D
25 +2.2 (c 0.075, MeOH); UV (sh, MeOH) λmax nm (ε): 257 (6100); 
CD (MeOH) λext nm [θ]: 323 (+87,000), 258 (-129,000); IR (neat) 3419, 1685 cm
-1; 
1H-NMR (600 
MHz, CDCl3) δ ppm: 5.93 (1H, s), 5.18 (1H, br t, J = 6.9 Hz), 4.18 (1H, t, J = 6.4 Hz), 2.71 (1H, d,  
J = 9.1 Hz), 2.35 (2H, m), 1.96 (3H, s), 1.93 (1H, m), 1.90 (1H, br s), 1.82 (1H, m), 1.75 (3H, s), 1.69 
(1H, m), 1.67 (3H, s), 1.64 (1H, m), 1.55 (3H, s), 1.35 (1H, m), 1.25 (1H, m), 1.21 (3H, s); 
13C-NMR 
(150 MHz, CDCl3) δ ppm: 212.7, 172.2, 144.3, 137.4, 134.9, 119.9, 115.6, 76.4, 56.7, 54.8, 37.5, 34.2, 
28.9, 25.9, 24.8, 22.5, 18.0, 16.7, 14.4; HRESIMS (m/z) calcd. for C19H28O2Na (M+Na)
+ 311.1987, 
found 311.1981. Anal. Calcd. for C19H28O2: C, 79.12; H, 9.78. Found: C, 78.97; H, 9.74.   
12-epi-21: [α]D
25 -113.7 (c 0.085, MeOH); UV (sh, MeOH) λmax nm (ε): 254 (2,100); CD (MeOH) λext 
nm [θ]: 320 (+116,000), 256 (-104,000); IR (neat) 3418, 1686 cm
-1; 
1H-NMR (600 MHz, CDCl3) δ 
ppm: 5.92 (1H, s), 5.16 (1H, t, J = 7.2 Hz), 4.19 (1H, t, J = 6.3 Hz), 2.71 (1H, d, J = 9.1 Hz), 2.35 (2H, 
m), 1.96 (3H, s), 1.93 (1H, m), 1.81 (1H, m), 1.74 (3H, s), 1.69 (1H, m), 1.67 (3H, s), 1.62 (1H, m), 
1.55 (3H, s), 1.35 (1H, m), 1.25 (1H, m), 1.22 (3H, s); 
13C-NMR (150 MHz, CDCl3) δ ppm: 212.8, 
172.2, 144.3, 137.4, 134.8, 119.9, 115.9, 76.5, 56.7, 54.7, 37.5, 34.1, 28.9, 25.9, 24.8, 22.5, 18.0, 16.7, 
14.1; HRESIMS (m/z) calcd. for C19H28O2Na (M+Na)
+ 311.1987, found 311.1975. Anal. Calcd. for 
C19H28O2: C, 79.12; H, 9.78. Found: C, 79.03; H, 9.88. 
 
3.21. General procedure for the synthesis of MPA ester 
 
To a solution of xestenone (21) in CH2Cl2 were added DCC, DMAP and (S)-(+)- or (R)-(-)-α-
methoxyphenylacetic acid at r.t. After stirring for 30 min at 40 °C the mixture was concentrated. 
Removal of the solvent gave a residue which was then purified by silica gel column chromatography 
(hexane/AcOEt = 6:1) to generate (S)- or (R)-MPA ester. (S)-MPA ester: 
1H-NMR (400 MHz, CDCl3) 
δ ppm: 7.44–7.27 (5H, m), 5.66 (1H, s), 5.26 (1H, dd, J = 7.9, 5.7 Hz), 5.06 (1H, m), 4.75 (1H, s), 3.43 
(3H, s), 2.62 (1H, d, J = 9.2 Hz), 2.39 (2H, m), 1.88 (1H, m), 1.76 (1H, m), 1.70 (3H, s), 1.68 (3H, s), 
1.61 (3H, s), 1.59 (2H, m), 1.30 (1H, m), 1.26 (3H, br s), 1.19 (1H, m), 1.15 (3H, s); 
13C-NMR  
(150 MHz, CDCl3) δ ppm: 211.9, 169.8, 139.2, 137.0, 134.6, 128.8, 128.5, 128.2, 127.2, 119.0, 118.1, 
117.8, 82.6, 79.0, 56.6, 54.7, 37.4, 31.8, 29.7, 28.8, 25.8, 24.7, 22.5, 18.0, 16.5, 14.4; HRESIMS (m/z) 
calcd. for C28H36O4Na (M+Na)
+ 459.2511, found 459.2521; (R)-MPA ester: 
1H-NMR (400 MHz, 
CDCl3) δ ppm: 7.45–7.29 (5H, m), 5.88 (1H, s), 5.24 (1H, dd, J = 7.7, 5.7 Hz), 4.80 (1H, m), 4.77 (1H, 
s), 3.43 (3H, s), 2.67 (1H, d, J = 9.0 Hz), 2.28 (2H, m), 1.91 (1H, m), 1.85 (3H, s), 1.81–1.59 (3H, m), 
1.53 (3H, s), 1.48 (3H, br s), 1.47 (3H, s), 1.33 (1H, m), 1.22 (1H, m), 1.19 (3H, s); 
13C-NMR  
(150 MHz, CDCl3) δ ppm: 212.1, 170.0, 139.5, 137.0, 134.4, 128.8, 128.5, 128.2, 127.2, 119.0, 118.7, Mar. Drugs 2009, 7       
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117.8, 82.6, 79.0, 56.7, 54.7, 37.5, 31.9, 29.7, 28.9, 25.6, 24.8, 22.5, 17.8, 16.6, 16.5; HRESIMS (m/z) 
calcd. for C28H36O4Na (M+Na)
+ 459.2511, found 459.2501. 
 
3.22. Conversion of 12-epi-21 to 21 
 
To a solution of 12-epi-21 (1.7 mg, 0.006 mmol) in THF (59 μL) were added Ph3P (2.3 mg,   
0.009 mmol) and p-NO2BzOH (1.5 mg, 0.009 mmol) at r.t. After stirring for 10 min, DIAD (1.8 mg, 
0.009 mmol) was added and the mixture was stirred for an additional 2 hr. The crude mixture was 
diluted with Et2O and filtered through a silica gel pad. The filtrate was then concentrated to afford the 
crude ester. To a solution of the crude ester in MeOH (200 μL) was added K2CO3 (12.2 mg,   
0.088 mmol) at r.t. After stirring for 30 min at the same temperature, the mixture was diluted with 
Et2O and then filtered through a silica gel pad. Removal of the solvent gave a residue which was then 
purified by silica gel column chromatography (hexane/AcOEt = 2:1) to generate xestenone (21,  
1.6 mg, 95% yield). 
 
4. Conclusions 
 
The first total synthesis of xestenone has been accomplished via the stereocontrolled one-pot 
synthesis of cyclopentane derivatives using allyl phenyl sulfone as the key step. Moreover, the authors 
have determined that the absolute configuration of xestenone is 3S, 7S and 12R. 
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